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The mechanism whereby surface antigens, after
cross-linking by appropriate antibodies, form a
cap at one region of the cell (11) is unknown .
Various schemes put forward to explain the phe-
nomenon canbe subdivided into twomain classes.
One set of models suggests that when antigens are
cross-linked to form patches, they are directly or
indirectly recognized by cytoskeletal elements
within the cell cytoplasm, and that theseelements
move the patch to a pole of the cell where they
form acap . This view is supported bymany reports
(see the review by de Petris [5]), which provide
indirect evidence for it . The alternative set of
models suggests that the processofcapping reflects
a polar movement of the cell's surface membrane
(1) or selected components of it (3) . There is little
published evidence in favor of these flow mecha-
nisms .
It is difficult to conceive of any direct experi-
ment to distinguish these quite different models .
However, one scheme requires recognition of the
patch from within the cell ; the other does not . If
an antigenon the surface of a cell, which isknown
not to be in contact with the cytoplasm, were
found to cap when cross-linked by antibody, then
this could be construed as evidence for a flow
scheme .The ideal antigen to use in this case would
be a lipid, because by its nature it extends only
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When motile cells are incubated with Forssman glycolipid, the antigen is incor,
porated into the cells' plasma membranes . If cross-linkedby antibody, thepatched
glycolipids cap . This process is sensitive to those drugs that are known to inhibit
capping of protein antigens . The results support a flow mechanism for capping.
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half-way through the bilayer and does not extend
to the cytoplasm .
Here we show that various cells, which lack
Forssman antigen (FA),' will bind a monoclonal
anti-Forssman antibody after the cells have been
incubated in Forssman glycolipid. This leads to a
uniform cover of antibody on the cell surface .
When cross-linked, these glycolipids cap .
The monoclonal antibody MI/22.25, which recognizes
a FA determinant (10), was used to assayFA during its
purification from sheep erythrocytes by its ability to
inhibitM1/22.25 cytotoxicity forsheep erythrocytes . The
glycolipid was purified by the procedure of Fraser and
Mallette (8) from 164 g of an acetone powder of sheep
erythrocytes, the final stages of purification being thin-
layer chromatography in chloroform:methanol:water
(65:25:4; Rf = 0.23) and n-propanol:water (70:30; Rf =
0.68). In both these systems, and in three additional ones
(chloroform:methanol:water [60:45:10; Rf = 0.8] ; chlo-
roform:methano1:2 .5 N NH40H [130:90:18 ; Rf = 0.45] ;
and n-propanol :6NNH 40H [2 :1 ; Rf=0.5], the material
contained a single component as seen by primuline
staining, which comigrated with the biological activity .
'Abbreviations used in this paper : CS, calf serum; DNP,
2,4 dinitrophenol; FA, Forssman antigen ; M1/22.25, cell
line producing monoclonal anti FA antibodies; R.anti-
Rat Ig-Fl or -Ft, rabbit anti-rat immunoglobulin anti-
bodies conjugated to fluorescein or ferritin ; PBS, phos-
phate-buffered saline .
829The yield of FA glycolipid (9 .1 mg) is considerably
higher than reported (12); this is probably due to a
different breed of sheep being used .
Insertion of FA glycolipid into various cells (l0) which
are FA negative was carried out by incubating them at
107 cells/ml in RPMI-1640 containing 10%o calf serum
(CS) and FA at l mg/ml (unless otherwise stated) for 2
h at 37°C . The cells were washed three times in phos-
phate-buffered saline (PBS) containing 10% CS.
In some cases, cells were fixed before labeling with
antibodies . This was done in 4% glutaraldehyde in PBS
for 30 min at 23°C . The cells were then washed in PBS,
held in 0.1 M L-lysine in PBS for 30 min at 23°C, and
then washed in PBS .
For fluorescence microscopy, cells were indirectly la-
beled by incubation in excess M1/22.25 antibodies in
PBS with or without 0.2% sodium azide for 30 min at
23°C . These monoclonal antibodies had been partially
purified from tissue culture medium by precipitation
with 45% ammonium sulphate. After a single wash, the
cells were incubated for 30 min in Miles-Yeda rabbit
anti-rat immunoglobulin antibodies conjugated to fluo-
rescein (R.anti-Rat Ig-Fl) diluted l:5 in PBS containing
10% CS and with, or without, 0.2% sodium azide at the
temperature specified . Washed cell suspensions were
mounted on slides andexamined in a Zeiss photomicro-
scope modified for epifluorescence microscopy (Carl
Zeiss, Inc., New York) . At least 200 cells were counted
where figures are given . Photographs were taken on
Kodak Tri-X film .
For immunoelectron microscopy, cells were labeled
first with excessM1/22.25 antibodies as described above,
followed by 10 mg/ml R.anti-Rat Ig-ferritin (Ft) (7) .
The labeled cells were fixed and prepared for electron
microscopy (7) .
RESULTS
The monoclonal antibody M1/22.25 has been
shown to recognize a FA determinant (10). We
have used these antibodies to assay this antigen
during its purification from sheep red blood cells .
TheM1/22.25 reactive molecule, a glycolipid, be-
haves during this isolation like FA (8). It is a pure
preparation, because its ability to inhibitM1/22.25
cytotoxicity for sheep erythrocytes comigrates with
a single glycolipid in five thin-layer chromatogra-
phy systems .
Mouse thymocytes, which are FA negative (10),
were used to test the incorporation ofexogenously
added FA into their membranes . The thymocytes
were incubated in various concentrations of FA,
and then labeled by successive incubation inM 1/
22.25 antibodies in azide at 23°C, followed by
R.anti-Rat Ig-Fl at 23 °C in azide . The cells were
examined for fluorescent staining. As seen in Fig .
1, positive cells can be detected following incuba-
tion in as little as 10 pg/mlFA . The FA glycolipid
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￿
Insertion of FA glycolipid into mouse thy-
mocytes.
can also be inserted into the membranes of a
variety of other cell types which do not normally
express this antigen, including lymphomas and
fibroblasts (Table I) . Not all cell types incorporate
the same amount of the glycolipid, as judged by
the relative intensities of their fluorescence. For
example, the Abelson lymphoma cells are only
weakly fluorescent whereas the other cell types
exhibit much stronger fluorescence . Following the
initial incubation with Forssman glycolipid, thy-
mus,N115, P815, andBW cells were washed and
incubated for a further 18 h in RPMI-1640 con-
taining 10% CS . These cells were then labeled with
M1/22.25 antibodies and R.anti-Rat Ig-Fl ; the
majority ofcells retain the added FA which is thus
stably bound to these cells. When the FA-incu-
bated cells are labeled with directly conjugated
fluorescent M1/22.25 antibodies, they show a
smooth, nonpatchy membrane fluorescence (data
not shown) . A similar distribution is obtained if,
after the FA incubation, the cells are prefixed with
glutaraldehyde and indirectly labeled (Fig . 2aand
b) . When the FA-positive cells are labeled at 4°C
in the presence of azide by indirect immunofluo-
rescence, the antigen is observed to have a patchy
distribution over the whole cell (Fig . 2c and d.) .
The smooth distribution of the inserted FA as
visualized by direct immunofluorescence or indi-
rectly following fixation suggests that the antigen
is not simply sticking to the surface of the cells .
To investigate this further, P815 cells with insertedFIGURE 2
￿
Distribution of inserted FA on P8l5 cells.
(a and b) Fixed cells were indirectly labeled at 37°C . (c
and d) Cells were indirectly labeled at 4°C in azide . (e
andf) Cells were indirectly labeled at 37°C . Fig . 2a, c,
ande: fluorescence ; Fig. 2b, d, andf . bright field . Bar, 5
gm; x 1,700 .
FA were indirectly labeled and visualized at the
electron microscope level using ferritin-conjugated
second layer antibodies. The distribution in em-
bryonal carcinoma cells, a naturally FA-positive
TABLE I
Insertion of FA Glycolipid into Various Cells
Cells were incubated (') in FA or ($) in its absence, and then indirectly labeled at 4°C and in azide . An aliquot of
the labeled cells was washed in PBS containing 10% CS and incubated for a further 30 min at 37°C, and the
proportion of cells with caps (< 1/3 cell surface fluorescent) was counted .
cell type (10),was examined forcomparison under
the same labeling conditions (azide, 4°C) . This is
shown in Fig. 3 ; both cell types, FA positive by
incorporation (Fig . 3 a) or biosynthesis (Fig . 3 c),
have ferritin molecules distributed in patches fairly
evenly over the surface of the cell and in close
apposition to its membrane. No labeling of P815
cells is seen without prior incubation with FA (Fig .
3 b) or of embryonal carcinoma cells ifM1/22.25
antibodies are omitted from the labeling proce-
dures (Fig . 3d) . When naturally or inserted FA-
positive cells are prefixed and then indirectly la-
beled withjerritin-conjugated antibodies, the fer-
ritin molecules are found uniformly distributed
over the whole cell's surface (data not shown) .
These results suggest that the exogenously added
glycolipid has inserted into the lipid bilayer of the
cell .
When the inserted glycolipid is cross-linked by
addition of Ml/22.25 antibodies followed by
R.anti-Rat Ig-Flunderconditions which allow the
redistribution of cross-linked membrane antigens
(no azide, 37°C), all the cell types examined ex-
hibited cells on whichthe membrane fluorescence
had moved to the pole of the cells and formed
caps (Table I and Fig . 2eandf) .
Antibody-induced redistribution ofendogenous
membrane antigens to form caps is known to be
sensitive to metabolic inhibitors (azide, 2,4-dini-
trophenol [DNPJ) and to the combined effects of
colchicin and cytochalasin B (11). P815 and EL4
cells, whichhad been incubated in FA,were tested
for their ability to cap the antigen in the presence
of various drugs . The cells were incubated with
M1/22.25 at 23°C, washed, incubated with R.anti-
Rat Ig-Fl at 37°C and washed, all these stages
being carried out in the presence of the drug in
RAPID COMMUNICATIONS
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Cell line Strain Cell type
Fluorescent
+FA "
cells
-FAT Capped cells
%
EL4 C57BL/6 Thymoma >95 0 >95
Bl0A.A2.P5 B10A Abelson lymphoma >95 0 40
BW 5147 AKR Thymoma >95 0 >95
P815 DBA/2 Mastocytoma >95 0 27
N115 A/J Neuroblastoma >95 0 17
PY-3T3 Swiss Polyoma transformed >95 0 14
fibroblastsFIGURE 3 Immuno-electron microscopy: Labeling of
cells with M1/22.25 antibodies and R.anti-Rat Ig-Ft . (a)
P815 cells preincubated with 1 mg/ml FA, labeled at
4°C in azide . (b),P815 cells preincubated in RPMI-1640
and labeled as for Fig. 3a. (c) Nulli-SCCI embryonal
carcinoma cells labeled as for Fig. 3a. (d) Nulli-SCCI
embryonal carcinoma cells labeled as for Fig . 3 b omit-
ting M1/22.25 antibodies in the first stage . Ferritin mol-
ecules are seen in clusters close to the membrane on
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TABLE II
Inhibition of Capping of Inserted FA Glycolipid
DISCUSSION
All drugs (except colchicin) were added from a 100 x
stock solution in DMSO .
question . The data in Table II illustrate that these
drugs affect capping of inserted FA glycolipid in
a manner similar to their effects on the capping of
protein antigens.
We have taken a glycolipid, FA, and added it to
the membranes of a variety of motile cells . Al-
though it is never possible to state with certainty
that a newly addedlipid becomes inserted into the
lipid bilayer of the recipient cell's plasma mem-
brane, our evidence-the stability of association
and the electron microscope study-is compatible
with correct insertion . This glycolipid, when cross-
linked by antibodies, behaves like anormalmem-
brane antigen with respect to ligand-induced re-
distribution . Previously, otherworkershave shown
that theglycolipid,GM 1, will redistribute on cells
when cholera toxin, bound to it, is cross-linked (4,
9) . It might be argued, in their case, that the
glycolipid (which is normally present in their cells)
or the toxin binds to an endogenous protein and
that the redistribution reflects, in effect, thecross-
linkage of these receptors. There are two reasons
whywe think this possibility is unlikely here . First,
we have studied a variety of cell types (Table I),
all normally FA negative . If capping were due to
specific association of FA with a protein in the
membranesof these cells, allthese cell typeswould
have to have such receptors . Second, it is improb-
able that the pentasaccharide head group of FA
could bind to a specific antibody binding site and
a separate protein receptor at the same time .
P815 cells with inserted FA (a) . No labeling of P815 cells
occurs without FA treatment (b) . The distribution of
ferritin moleculeson the membrane of Nulli-SCCI em-
bryonal carcinoma cells, a naturally FA-positive cell
type, is similar to that seen with P815 cells treated with
exogenous FA (c) . No labeling of the embryonal carci-
noma cells occurs if M1/22.25 antibodies are omitted
from the labeling procedure (d) . Bar, 0.25 pm . x 35,000.
Pretreatment PBt5
capped
EL4
cells
None (1% DMSO) 26 .8 73 .0
Colchicin (10-" M) 21 .7 72 .7
Cytochalasin B (10wg/ml) 20 .4 32 .3
Colchicin (10-" M) + cytochalasin 5.8 3.5
B (10wg/ml)
DNP (10 mM) 3.4 3 .0Because glycolipids can extend only into a bi-
layer but not across it, these results indicate that
the process of capping of these antigens (and,
possibly, other antigens) cannot be mediated by
direct linkage of a cytoskeletal network to the
patch . They do not rule out schemes involving
hypothetical molecules X (2), which specifically
recognize the cross-linkage of antigens on the out-
side of the cell, although we believe such models
unlikely . That cross-linked glycolipids cap can be
fitted into a scheme for capping in which either
the membrane or the bulk phase lipids are in a
continual state of directed flow (1, 3) . The patched
lipids would simply move along with the flow,
away from the region of the cell wheremembrane
or lipid is inserted.
There are three additional points we should like
to make . First, a flow scheme requires a separation
between the sites of insertion and withdrawal of
membrane, but they need not both be unique sites .
In a fibroblast, the site of insertion is most likely
the ruffling membrane at the leading edge, and
the site of membrane retrieval the whole cell's
surface . Second, the two extreme schemes for cap-
ping (by direct interaction with the cytoskeleton
or by a flow mechanism) are not the only viable
models . For instance, it is conceivable that a motile
cell continually rakes its surface, the teeth of the
rake being situated across the plasma membrane
and the handle inside the cell (perhaps being part
of the cytoskeleton) (6) . This is similar to a flow
scheme, in the sense that no specific recognition
of cross-linkage is involved . In both cases, any
object of sufficient size (which gets caught in the
teeth of the rake or cannot diffuse against the
flow) would cap . Finally, it is widely assumed that
the effects of cytochalasin B and colchicin on
capping are due to their inhibition ofthe functions
of microfilaments and microtubules, respectively .
If this is in fact so, then the observations that
neither drug alone eliminates capping and that
they have a synergistic effect indicate that the role
ofmicrofilaments and microtubules in the capping
process is not a simple one .
We thank Susan Baker for excellent technical work .
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